Radiosurgery and Radiotherapy Robotics Market Report 2026

The radiosurgery and radiotherapy robotics market size has grown strongly in recent years. It will grow from $4.54 billion in 2025 to $4.79 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increasing cancer incidence rates, expansion of hospital-based oncology infrastructure, adoption of advanced linear accelerator systems, growing acceptance of minimally invasive cancer treatments, improvements in radiation delivery accuracy.

The radiosurgery and radiotherapy robotics market size is expected to see strong growth in the next few years. It will grow to $6.17 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing investments in robotic oncology platforms, rising demand for personalized cancer treatment, expansion of proton therapy centers, growing integration of ai-driven treatment planning, increasing focus on reducing radiation exposure to healthy tissues. Major trends in the forecast period include increasing adoption of robotic-assisted precision radiation systems, growing integration of image-guided treatment platforms, rising use of adaptive radiotherapy technologies, expansion of proton and stereotactic radiosurgery systems, enhanced focus on treatment accuracy and patient safety.

The increasing demand for minimally invasive procedures is expected to drive the growth of the radiosurgery and radiotherapy robotics market. Minimally invasive procedures are surgical techniques performed through small incisions in the body. These procedures typically use specialized instruments and cameras inserted through the incisions. Radiosurgery and radiotherapy robots are used in minimally invasive treatments to deliver radiation doses to tumors with greater accuracy and precision compared to conventional approaches. This is due to the ability of robots to operate with higher consistency and precision than human hands. For instance, in February 2024, according to the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, in 2023, the majority of medical procedures, accounting for 83%, were minimally invasive, while 17% were traditional surgical procedures. Therefore, the growing demand for minimally invasive procedures is contributing to the growth of the radiosurgery and radiotherapy robotics market.

Major companies operating in the radiosurgery and radiotherapy robotics market are concentrating on adopting advanced technologies, such as dynamic surface positioning and monitoring systems, to maintain their market presence. These systems are patient tracking solutions for surface-guided radiation therapy that use thermal-surface cameras to monitor patient positioning and detect movement during treatment. For instance, in May 2023, Brainlab, a Germany-based developer of radiotherapy and radiosurgery software and hardware, launched the ExacTrac Dynamic Surface Positioning and Monitoring System. This single-camera solution enables consistency across radiation departments and supports continuous patient monitoring during breath-hold treatments. The primary objective of ExacTrac Dynamic Surface is to establish department-wide uniformity and ensure accurate tracking. Clinicians benefit from a short learning curve when using ExacTrac Dynamic Surface on any linear accelerator due to its single, user-friendly interface and standardized workflows.

In April 2024, Elekta AB, a Sweden-based medical technology company, partnered with MIM Software Inc. to incorporate MIM’s advanced, vendor-agnostic imaging and auto-contouring technologies into Elekta’s radiation therapy planning ecosystem. Through this partnership, Elekta seeks to strengthen its radiosurgery and radiotherapy planning capabilities by streamlining clinical workflows, enhancing treatment accuracy, and improving throughput for cancer care. MIM Software Inc. is a US-based provider of medical imaging management and AI-enabled radiation oncology software.

Major companies operating in the radiosurgery and radiotherapy robotics market are Mitsubishi Electric Corporation, Hitachi Ltd., Siemens Healthineers AG, Elekta AB, Shinva Medical Instrument Co. Ltd., Neusoft Medical Systems Co. Ltd., Accuray Incorporated, Sumitomo Heavy Industries Ltd., Ion Beam Applications SA, Brainlab AG, ViewRay Inc., Zhuhai Hokai Medical Instruments Co. Ltd., RaySearch Laboratories AB, Mevion Medical Systems Inc., Vision Rt Limited, Sun Nuclear Corporation, Panacea Medical Technologies Pvt. Ltd., C-Rad AB, Radiadyne LLC, ProTom International Holding Corporation, CIVCO Radiotherapy, Standard Imaging Inc., Intraop Medical Corporation, Best Medical International Inc., Modus Medical Devices Inc., Mirada Medical Ltd.

North America was the largest region in the radiosurgery and radiotherapy robotics market in 2025. The regions covered in the radiosurgery and radiotherapy robotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the radiosurgery and radiotherapy robotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the radiosurgery and radiotherapy robotics market by increasing costs of imported robotic arms, precision actuators, imaging components, radiation delivery modules, and advanced control software. Hospitals and cancer treatment centers in North America and Europe are most affected due to dependence on imported high-value medical robotics, while Asia-Pacific faces cost pressure on equipment procurement and installation. These tariffs are increasing capital expenditure requirements and extending procurement cycles. However, they are also encouraging localized assembly, regional manufacturing partnerships, and domestic innovation in medical robotics technologies.

The radiosurgery and radiotherapy robotics market research report is one of a series of new reports that provides radiosurgery and radiotherapy robotics market statistics, including radiosurgery and radiotherapy robotics industry global market size, regional shares, competitors with a radiosurgery and radiotherapy robotics market share, detailed radiosurgery and radiotherapy robotics market segments, market trends and opportunities, and any further data you may need to thrive in the radiosurgery and radiotherapy robotics industry. This radiosurgery and radiotherapy robotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Radiosurgery and radiotherapy robotics refer to medical procedures that utilize advanced technologies to administer highly precise radiation doses to targeted areas of the body. These approaches are used in the treatment of a wide range of medical conditions and play a vital role in contemporary medical practice. Robotics-assisted techniques improve the effectiveness of cancer treatments while reducing damage to surrounding healthy tissues.

The primary product types included in radiosurgery and radiotherapy robotics are x-ray based, gamma-ray based, and proton-beam based systems. X-rays are a type of electromagnetic radiation with higher energy than visible light and the ability to penetrate most materials. They are used across multiple applications, including external beam radiotherapy and internal beam radiotherapy or brachytherapy, and are utilized by various end users such as hospitals, clinics, and others.

The radiosurgery and radiotherapy robotics market consists of sales of gamma knife, robotic arm, linear accelerator, imaging systems and TrueBeam system. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.